8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): July 1, 2018

Rennova Health, Inc.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

001-35141	68-0370244
(Commission File Number)	(I.R.S. Employer Identification No.)

400 S. Australian Avenue, Suite 800, West Palm Beach, Florida	33401
(Address of Principal Executive Offices)	(Zip Code)

(561) 855-1626

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Board of Directors of Rennova Health, Inc. (the “Company”) appointed Marlene McLennan as our Chief Financial Officer effective July 1, 2018. Seamus Lagan, our Chief Executive Officer, had also been serving as interim Chief Financial Officer.

Ms. McLennan, 47, has been Vice President of Finance of the Company since April 2, 2018. Previously, she served as Chief Financial Officer of Medbridge Healthcare LLC, a leading provider of sleep laboratory management services and sleep therapy, from June 2017 to March 2018. Ms. McLennan, from February 2016 to April 2017, was the Chief Financial Officer of Barnes Healthcare Services, one of the largest privately-owned home care companies in the country. From May 2015 to January 2016, she served as the Chief Financial Officer of Cascadia Behavioral Healthcare, a 501(c)(3) not-for-profit organization in the behavioral and residential health arena. Ms. McLennan also was the Chief Financial Officer of Monroe County Hospital, a comprehensive healthcare system serving Monroe County and surrounding areas in Georgia, from January 2012 to February 2015.

Ms. McLennan has no family relationship with any of the executive officers or directors of the Company. There are no arrangements or understandings between Ms. McLennan and any other person pursuant to which she was appointed as an officer of the Company.

A copy of the press release issued by the Company announcing Ms. McLennan’s appointment is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Exhibit Description
99.1	Press Release dated July 3, 2018

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 3, 2018	RENNOVA HEALTH, INC.
	By:	/s/ Seamus Lagan
		Seamus Lagan
		Chief Executive Officer
		(principal executive officer)

3

EX-99.1

 

Rennova Health WELCOMES new chief financial officer

WEST PALM BEACH, Fla. (July 3, 2018) – Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its second rural hospital in Tennessee on June 1, 2018, announces that its Board of Directors has appointed Marlene McLennan to the position of Chief Financial Officer (CFO) effective July 1st.

Mrs. McLennan has worked as VP of Finance for Rennova since April 2, 2018 and has extensive healthcare experience as a Senior Executive in all areas of financial and business operations in the public and private healthcare sector. Mrs. McLennan has worked with several healthcare service providers in the role of Chief Financial Officer since 2005.

Prior to her appointment with Rennova, Mrs. McLennan was CFO at MedBridge Healthcare, Inc. based out of Greenville, South Carolina, where she oversaw the daily operations of accounts payable, accounts receivable, finance, accounting and human resources for in excess of 130 hospitals, as well as having direct oversight and management in the areas of revenue cycle and managed care contracting. During her time at MedBridge she improved daily collections by nearly 27% as well as improving accounts receivable from 50+ days to just 38 days.

“It is imperative to add knowledge and expertise to our team as we grow our business in the rural hospital sector,” said Seamus Lagan CEO of Rennova. “Marlene has a proven track record in this sector and will add value to existing operations and future opportunities.”

“I look forward to using my experience in refining operations and financial reporting at numerous rural hospitals over the years to maximize the value for Rennova and its shareholders in the areas in which it is now focusing,” said Mrs. McLennan, new CFO of Rennova. “Like Rennova, I believe there are significant opportunities in this sector. I look forward to being part of a team that has the vision to pursue growth and acquisitions and that provides needed services to the communities we serve and those we will serve in the future.”

About Rennova Health, Inc.

Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Contacts:

Rennova Health, Inc.

Sebastien Sainsbury, 561-666-9818

ssainsbury@rennovahealth.com

# # #